- Filed
- Mar 19, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 18, 2025 | 3.45M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 3.43M sh |
| Capex | FY 2024 · Dec 31, 2023 | $70K |
| Operating Cash Flow restated | FY 2024 · Dec 31, 2023 | $321K |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $9.87M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $690K |
| Current Assets | FY 2024 · Dec 31, 2023 | $13.14M |
| Total Assets | FY 2024 · Dec 31, 2023 | $14.45M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | $0.08 |
| Eps Basic | FY 2024 · Dec 31, 2023 | $0.08 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $1.97M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $973K |
| Net Income | FY 2024 · Dec 31, 2023 | $275K |
| Operating Income | FY 2024 · Dec 31, 2023 | −$28K |
| Gross Profit | FY 2024 · Dec 31, 2023 | $4.25M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $4.31M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $13.41M |